Ultragenyx Pharma (RARE) PT Lowered to $115 at Piper Sandler 'Ahead of Near-Term Value Inflection'
Tweet Send to a Friend
Piper Sandler analyst Allison M. Bratzel lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $115.00 (from $140.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
